Ionis Pharma (NASDAQ: IONS) reported Q4 EPS of $0.21, $0.33 better than the analyst estimate of ($0.12). Revenue for the quarter came in at $160.3 million versus the consensus estimate of $97.47 million.

For earnings history and earnings-related data on Ionis Pharma (IONS) click here.